ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,796.00
0.34%
S&P ASX All Technology
3,092.40
0.70%
Brent Oil
84.39
0.00%
US Dollar vs AUD
1.50581
0.60%
Bitcoin
64,085.45
-0.25%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. bioAffinity Technologies Inc (BIAF)

  7. bioAffinity Technologies Inc (BIAF) News

BIAF

bioAffinity Technologies (BIAF)

bioAffinity Technologies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIAF
DateTimeSourceHeadlineSymbolCompany
12/06/202422:00Business WirebioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsNASDAQ:BIAFbioAffinity Technologies Inc
15/05/202423:15Business WirebioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesNASDAQ:BIAFbioAffinity Technologies Inc
02/05/202422:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFbioAffinity Technologies Inc
24/04/202422:00Business WirebioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthNASDAQ:BIAFbioAffinity Technologies Inc
09/04/202422:00Business WirebioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningNASDAQ:BIAFbioAffinity Technologies Inc
02/04/202400:49Business WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BIAFbioAffinity Technologies Inc
09/03/202409:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
09/03/202405:15PR Newswire (US)Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
09/03/202404:45Business WirebioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
09/03/202404:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
08/03/202413:57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
07/03/202402:45PR Newswire (US)WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
07/03/202401:46Business WirebioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
06/03/202409:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
06/03/202400:00Business WirebioAffinity Technologies Reports Accelerating Sales Growth of CyPath® LungNASDAQ:BIAFbioAffinity Technologies Inc
22/02/202400:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFbioAffinity Technologies Inc
07/02/202400:00Business WireMedical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical PracticeNASDAQ:BIAFbioAffinity Technologies Inc
03/02/202408:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
03/02/202408:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
03/02/202408:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
03/02/202408:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
01/02/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
31/01/202400:00Business WirebioAffinity Technologies In The NewsNASDAQ:BIAFbioAffinity Technologies Inc
25/01/202412:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
25/01/202412:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
25/01/202412:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
24/01/202400:00Business WirebioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of CancerNASDAQ:BIAFbioAffinity Technologies Inc
09/01/202400:00Business WirebioAffinity Technologies In the NewsNASDAQ:BIAFbioAffinity Technologies Inc
09/12/202308:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
06/12/202300:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:BIAF

Your Recent History

NASDAQ
FNSC
NASDAQ
FTDS
First Trust Dividend Str...
AMEX
SZB
Southfirst Bkshr
ASX
POWR
BIT
UC7PXT
Unicredit Bank
BIT
S24946
SG ISSUER
LSE
68MT
Harbour 5.28%
NASDAQ
APWRU
NASDAQ
ULCC
Frontier
EU
BE0002882638
KBC Bank NV Kbcbk2.375%2...
BIT
P1Z9G0
NLBNPIT1Z9G0 20241220 2000
BIT
P1XTU1
NLBNPIT1XTU1 20351221 22...
LSE
JPI
JP Morgan Fleming & Cap It
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved